Cardiovascular
Cardiac Surgery
0
Pipeline Programs↗
36
Active Trials↗
9
Companies Involved↗
Cardiac Surgery is an early-stage landscape with 0 programs across 9 companies. The most active players are Novartis, Action Pharma A/S, Guard Therapeutics AB.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
264
clinical trials
Completed150 · 57%
Unknown status43 · 16%
Terminated23 · 9%
Recruiting18 · 7%
Not yet recruiting14 · 5%
Withdrawn11 · 4%
Other5 · 2%
Clinical Trials
Trial Activity
264 trials
Non-steroidal Anti-inflammatory in Cardiac Surgery
Recruiting·—·Phase 3·NCT06381063·238 enrolled
Intravenous Methadone for Sternotomy Pain Control in Cardiac Surgery
Recruiting·—·Phase 3·NCT06728371·86 enrolled
Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery
Recruiting·—·N/A·NCT05635227·1,200 enrolled
Patient Blood Management in Patients Scheduled for Cardiac Surgery
Recruiting·FFondazione Policlinico Universitario Agostino Gemelli IRCCS·N/A·NCT06637137·464 enrolled
ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
Recruiting·—·Phase 4·NCT06487585·100 enrolled
Evaluation of Clinical Impact of the Type of Cardioplegia Used in the Patient Undergoing Major Cardiac Surgery.
Recruiting·—·Phase 4·NCT06530641·600 enrolled
Page 1 of 18
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)